Approval · Notice of Compliance 36134 · 2025
ADCETRIS: Notice of Compliance 36134
Issued October 9, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36134
- Date
- October 9, 2025
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Merger/Buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADCETRIS | Not yet assigned | — |
Medicinal ingredients
- BRENTUXIMAB VEDOTIN 50 MG per VIAL